Anderman Todd

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Anderman Todd's trades of Ocular Therapeutix, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
363.55
Quantity 92,079
Value US$2,762,474
Transaction date
Proposed sale
Price
12.34
Quantity 11,132
Value US$137,400
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-13 2026-10-08
S Sale
98,841 -15.0%
281.20
US$1,436,092 		98,841 -15.0% 281.20 US$1,436,092
2026-10-08 2026-10-08
PrS Proposed sale
92,079
363.55
US$2,762,474 		92,079 363.55 US$2,762,474
2025-10-10 2025-10-08
S Sale
18,235 -14.0%
275.19
US$929,540 		18,235 -14.0% 275.19 US$929,540
2025-10-08 2025-10-08
PrS Proposed sale
11,132
12.34
US$137,400 		11,132 12.34 US$137,400